+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Cryptococcal Meningitis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Cryptococcal Meningitis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Chronic Hepatitis B Virus Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chronic Hepatitis B Virus Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Behcet's Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Behcet's Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Anal Fistula Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Anal Fistula Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Meningitis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Meningitis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Infantile Spasm Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Infantile Spasm Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Hepatitis D Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hepatitis D Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Gastroparesis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Gastroparesis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Myasthenia Gravis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Myasthenia Gravis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Marburg Virus Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Marburg Virus Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Neurodermatitis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Neurodermatitis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Gastric Ulcers Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Gastric Ulcers Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Diabetic Retinopathy Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Diabetic Retinopathy Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Preeclampsia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Preeclampsia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Cellulitis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Cellulitis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Pearson Syndrome Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Pearson Syndrome Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Dravet Syndrome (DS) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Achondroplasia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Achondroplasia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Astigmatism Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Astigmatism Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more